PharmaEngine, Inc. (TPEX:4162)
Taiwan
· Delayed Price · Currency is TWD 81.10
-3.80 (-4.48%)
Jun 13, 2025, 1:30 PM CST
PharmaEngine Revenue
PharmaEngine had revenue of 187.38M TWD in the quarter ending March 31, 2025, with 13.93% growth. This brings the company's revenue in the last twelve months to 2.55B, up 233.36% year-over-year. In the year 2024, PharmaEngine had annual revenue of 2.52B with 228.70% growth.
Revenue (ttm)
2.55B
Revenue Growth
+233.36%
P/S Ratio
4.58
Revenue / Employee
57.87M
Employees
44
Market Cap
11.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.52B | 1.76B | 228.70% |
| Dec 31, 2023 | 767.67M | 113.29M | 17.31% |
| Dec 31, 2022 | 654.38M | -452.00K | -0.07% |
| Dec 31, 2021 | 654.84M | -401.18M | -37.99% |
| Dec 31, 2020 | 1.06B | 741.97M | 236.27% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Lumosa Therapeutics | 43.59M |
| Center Laboratories | 1.63B |